Article
Genetic variation in FOXP2 alters grey matter concentrations in schizophrenia patients.
Neuroscience letters - 15 Apr 2011
Španiel Filip, Horáček Jiří, Tintěra Jaroslav, Ibrahim Ibrahim, Novák Tomáš, Čermák Jan, Klírová Monika, Höschl Cyril
Abstract excerpt
FOXP2, the first gene known to be involved in the development of speech and language, can be considered to be, a priori, a candidate gene in schizophrenia, given the mounting evidence that the underlying core deficit in this disease could be a failure of structures relevant to normal language processing. To investigate the potential link between grey matter concentration (GMC) changes in patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
